SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035170
Filing Date
2024-08-06
Accepted
2024-08-06 16:04:28
Documents
84
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcrx-20240630.htm   iXBRL 10-Q 1493462
2 EX-10.2 exhibit102-biocrystxfirsta.htm EX-10.2 6973
3 EX-10.3 exhibit103-biocrystpharmac.htm EX-10.3 17580
4 EX-10.4 exhibit104-biocrystsipperf.htm EX-10.4 46551
5 EX-31.1 bcrx-20240630xexx311.htm EX-31.1 9618
6 EX-31.2 bcrx-20240630xexx312.htm EX-31.2 9592
7 EX-32.1 bcrx-20240630xexx321.htm EX-32.1 4664
8 EX-32.2 bcrx-20240630xexx322.htm EX-32.2 4638
  Complete submission text file 0001628280-24-035170.txt   8208950

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcrx-20240630.xsd EX-101.SCH 60310
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcrx-20240630_cal.xml EX-101.CAL 67082
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcrx-20240630_def.xml EX-101.DEF 249496
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcrx-20240630_lab.xml EX-101.LAB 724048
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcrx-20240630_pre.xml EX-101.PRE 488571
87 EXTRACTED XBRL INSTANCE DOCUMENT bcrx-20240630_htm.xml XML 1189130
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 241179067
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)